Literature DB >> 18219318

A microRNA component of the hypoxic response.

R Kulshreshtha1, R V Davuluri, G A Calin, M Ivan.   

Abstract

microRNAs participate in a wide variety of physiological and pathological cellular processes. Recent studies have established a link between a specific group of microRNAs and hypoxia, a key feature of the neoplastic microenvironment. A significant proportion of the hypoxia-regulated microRNAs (HRMs) are also overexpressed in human cancers, suggesting a role in tumorigenesis. Preliminary evidence suggests that they could affect important processes such as apoptosis, proliferation and angiogenesis. Several HRMs exhibit induction in response to HIF activation, thus extending its repertoire of targets beyond translated genes. In the present review, we discuss the emerging roles of HRMs in oxygen deprivation in cancer context.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18219318     DOI: 10.1038/sj.cdd.4402310

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  126 in total

1.  Guest editorial: hypoxia biology in health and disease.

Authors:  Nobuhito Goda
Journal:  Int J Hematol       Date:  2012-05-02       Impact factor: 2.490

Review 2.  Invited review: decoding the microRNA response to hypoxia.

Authors:  Roger Pocock
Journal:  Pflugers Arch       Date:  2011-01-05       Impact factor: 3.657

Review 3.  Targeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressiveness.

Authors:  Bin Bao; Asfar S Azmi; Yiwei Li; Aamir Ahmad; Shadan Ali; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Curr Stem Cell Res Ther       Date:  2014-01       Impact factor: 3.828

4.  miR-210 inhibits trophoblast invasion and is a serum biomarker for preeclampsia.

Authors:  Lauren Anton; Anthony O Olarerin-George; Nadav Schwartz; Sindhu Srinivas; Jamie Bastek; John B Hogenesch; Michal A Elovitz
Journal:  Am J Pathol       Date:  2013-09-10       Impact factor: 4.307

5.  MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3.

Authors:  Pasquale Fasanaro; Yuri D'Alessandra; Valeria Di Stefano; Roberta Melchionna; Sveva Romani; Giulio Pompilio; Maurizio C Capogrossi; Fabio Martelli
Journal:  J Biol Chem       Date:  2008-04-16       Impact factor: 5.157

6.  Differential hypoxic regulation of the microRNA-146a/CXCR4 pathway in normal and leukemic monocytic cells: impact on response to chemotherapy.

Authors:  Isabella Spinello; Maria Teresa Quaranta; Rosa Paolillo; Elvira Pelosi; Anna Maria Cerio; Ernestina Saulle; Francesco Lo Coco; Ugo Testa; Catherine Labbaye
Journal:  Haematologica       Date:  2015-06-04       Impact factor: 9.941

7.  Recent advances in colorectal cancer research: the microenvironment impact.

Authors:  Anne-Laure Pin; François Houle; Jacques Huot
Journal:  Cancer Microenviron       Date:  2011-08

8.  Hypoxia-responsive miRNAs target argonaute 1 to promote angiogenesis.

Authors:  Zhen Chen; Tsung-Ching Lai; Yi-Hua Jan; Feng-Mao Lin; Wei-Chi Wang; Han Xiao; Yun-Ting Wang; Wei Sun; Xiaopei Cui; Ying-Shiuan Li; Tzan Fang; Hongwei Zhao; Chellappan Padmanabhan; Ruobai Sun; Danny Ling Wang; Hailing Jin; Gar-Yang Chau; Hsien-Da Huang; Michael Hsiao; John Y-J Shyy
Journal:  J Clin Invest       Date:  2013-02-15       Impact factor: 14.808

9.  Severe neonatal anemia increases intestinal permeability by disrupting epithelial adherens junctions.

Authors:  Krishnan MohanKumar; Kopperuncholan Namachivayam; Nithya Sivakumar; Natascha G Alves; Venkataramana Sidhaye; Jayanta K Das; Yerin Chung; Jerome W Breslin; Akhil Maheshwari
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-02-24       Impact factor: 4.052

10.  Expression profile of MicroRNAs in young stroke patients.

Authors:  Kay Sin Tan; Arunmozhiarasi Armugam; Sugunavathi Sepramaniam; Kai Ying Lim; Karolina Dwi Setyowati; Chee Woon Wang; Kandiah Jeyaseelan
Journal:  PLoS One       Date:  2009-11-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.